CLASS II Drug recall · Reported 19 Jun 2019 · FDA Enforcement Report

Senna (sennosides 8 mg) Syrup recalled by Geritrex

Geritrex is recalling Senna (sennosides 8 mg) Syrup, distributed nationwide in the US. The recall was initiated on 6 May 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 1806031, 1806014, Exp. 08/2019
Quantity recalled24312 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1437-2019
FDA event ID
82947
Recalling firm
Geritrex, Middletown, NY
Classification
Class II
Status
Terminated
Recall initiated
6 May 2019
FDA classified
28 Jun 2019
Reported
19 Jun 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

6 May 2019Recall initiated by company
19 Jun 2019Published in enforcement report+44 days
28 Jun 2019Classified by FDA+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Senna (sennosides 8.8 mg) Syrup 8 fl oz. (236 mL) bottles, Distributed by Geritrex, LLC 40 Commercial Avenue Middletown, NY 10941, NDC 54162-007-08

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Is Senna (sennosides 8 mg) Syrup recalled?

Yes. Geritrex recalled Senna (sennosides 8 mg) Syrup on 6 May 2019. The recall is Class II and its status is Terminated. Recall number D-1437-2019.

Why was it recalled?

Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Which lots are affected?

Lot #: 1806031, 1806014, Exp. 08/2019

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Geritrex

All 15